Bulletin
Investor Alert

Portage Biotech Inc.

NAS: PRTG

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 24, 2022, 4:44 p.m.

/zigman2/quotes/205701577/composite

$

8.86

Change

0.00 0.00%

Volume

Volume 517

Quotes are delayed by 20 min

/zigman2/quotes/205701577/composite

Previous close

$ 8.89

$ 8.86

Change

-0.03 -0.34%

Day low

Day high

$8.00

$8.99

Open

52 week low

52 week high

$8.00

$44.98

Open

Annual Financials for Portage Biotech Inc.

Operating Activities

Fiscal year is April-March. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries (641,274)123.74M(3.59M)(7.25M)(17.19M)
Depreciation, Depletion & Amortization -----
Depreciation and Depletion -----
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit ---1.24M2.45M
Deferred Taxes ---1.24M2.45M
Investment Tax Credit -----
Other Funds (628,940)(124.86M)2.02M2.41M11.2M
Funds from Operations (1.27M)(1.12M)(1.57M)(3.6M)(3.54M)
Extraordinaries -----
Changes in Working Capital (50,880)50,000715,000(114,000)(744,000)
Receivables 139,79932,000352,000(281,000)(1.59M)
Accounts Payable -----
Other Assets/Liabilities ----(36,000)
Net Operating Cash Flow (1.32M)(1.07M)(858,000)(3.71M)(4.28M)

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures -----
Capital Expenditures (Fixed Assets) -----
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions (3.41M)----
Sale of Fixed Assets & Businesses --1.19M--
Purchase/Sale of Investments -6.61M(688,000)-(860,000)
Purchase of Investments -(681,000)(688,000)-(1M)
Sale/Maturity of Investments -7.29M--140,000
Other Uses -(950,000)(950,000)--
Other Sources -----
Net Investing Cash Flow (3.41M)5.66M(446,000)-(860,000)

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock -2.73M--6.73M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock -2.73M--6.73M
Proceeds from Stock Options ----6.73M
Other Proceeds from Sale of Stock -2.73M---
Issuance/Reduction of Debt, Net 200,00050,000(50,000)(300,000)(1.02M)
Change in Current Debt -----
Change in Long-Term Debt 200,00050,000(50,000)(300,000)(1.02M)
Issuance of Long-Term Debt 200,00050,000---
Reduction in Long-Term Debt --(50,000)(300,000)(1.02M)
Other Funds ---1M(950,000)
Other Uses ----(1M)
Other Sources ---1M50,000
Net Financing Cash Flow 200,0002.78M(50,000)700,0004.76M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash (4.53M)7.36M(1.35M)(3.01M)(382,000)
Free Cash Flow (1.32M)-(858,000)(3.71M)(4.28M)
Trending Tickers
  • /zigman2/quotes/202561856/composite MSTR-17.84%
  • /zigman2/quotes/205315244/composite DHT-4.09%
X
Powered by StockTwits
Link to MarketWatch's Slice.